|
[1]Karl Citek, Bret Andre, Jan Bergmanson, James J. Butler, b. Ralph Chou, Minas t. Coroneo, Eileen Crowley, Dianne Godar, Gregory Good, Stanley J. Pope, David Sliney. The eye and solar ultraviolet radiation. Report of a roundtable. Report of a Roundtable. 2011; Salt lake City, UT, USA. [2]Lucas RM, Ponsonby AL. Ultraviolet radiation and health: friend and foe. MJA. 2002; 177(11-12): 594-598. [3]Cullen, AP. Photokeratitis and other phototoxic effects on the cornea and conjunctiva. Int J Toxicol. 2002; 21(6): 455-464. [4]Young, AR. Acute effects of UVR on human eyes and skin. Prog Biophys Mol Biol. 2006; 92(1): 80-85. [5]McMonnies CW. Epigenetic mechanisms might help explain environmental contributions to the pathogenesis of keratoconus. Eye & Contact Lens. 2014; 40(6): 371-375. [6]Wojcik KA, Kaminska A, Blasiak J, Szaflik J, Szaflik JP. Oxidative stress in the pathogenesis of keratoconus and Fuchs endothelial corneal dystrophy. Int J Mol Sci. 2013; 14(9): 19294-19308. [7]Cejka C, Cejkova J. Oxidative Stress to the Cornea, Changes in Corneal Optical Properties, and Advances in Treatment of Corneal Oxidative Injuries. Oxid Med Cell Longev. 2015; 591530. [8]Chen BY, Lin DP, Wu CY, Teng MC, Sun CY, Tsai YT, Su KC, Wang SR, Chang HH. Dietary zerumbone prevents mouse cornea from UVB-induced photokeratitis through inhibition of NF-κB, iNOS, and TNF-α expression and reduction of MDA accumulation. Mol Vis. 2011; 17:854-863. [9]Chen BY, Lin DP, Chang LS, Huang TP, Liu HJ, Luk CP, Lo YL, Chang HH. Dietary α-lipoic acid prevents UVB-induced corneal and conjunctival degeneration through multiple effects. Invest Ophthalmol Vis Sci. 2013; 54(10): 6757-66. [10]Chaerkady R, Shao H, Scott SG, Pandey A, Jun AS, Chakravarti S. The keratoconus corneal proteome: loss of epithelial integrity and stromal degeneration. J Proteomics. 2013; 87: 122-131. [11]Kenney MC, Brown DJ. The cascade hypothesis of keratoconus. Cont Lens Anterior Eye. 2003; 26(3): 139-146. [12]Lema I, Sobrino T, Durán JA, Brea D, Díez-Feijoo E. Subclinical keratoconus and inflammatory molecules from tears. 2009; 93(6): 820-824. [13]Toprak I, Kucukatay V, Yildirim C, Kilic-Toprak E, Kilic-Erkek O. Increased systemic oxidative stress inpatients with keratoconus. Eye (Lond). 2014; 28(3): 285-289. [14]Kenney MC, Brown DJ, Rajeev B. The elusive causes of keratoconus: a working hypothesis. Am J Ophthalmol. 2000; 130(2): 263. [15]Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA. 1997; 278(16): 1327-1332. [16]Matthew S, Taylor H. Ultraviolet radiation and the eye. Int Ophthalmol Clin. 2005; 45(1): 1-17. [17]Komai Y, Ushiki T. The three-dimensional organization of collagen fibrils in the human cornea and sclera. Invest Ophthalmology & Vis Sci. 1991; 32(8): 2244-2258. [18]Almubrad T, Akhtar S. Structure of corneal layers, collagen fibrils, and proteoglycans of tree shrew cornea. Mol Vis. 2011; 17: 2283-2291. [19]Murphy C, Alvarado J, Juster R, Maglio M. Prenatal and Postnatal Cellularity of the Human Corneal Endothelium. A Quantitative Hisrologic Study. Investigative Ophthalmology & Visual Science.1984; 25(3): 312-322. [20]Bates AK, Cheng H. Bullous keratopathy: a study of endothelial cell morphology in patients undergoing cataract surgery. British Journal of Ophthalmology. 1988; 72(6): 409-412. [21]Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998; 42(4): 297-319. [22]Kodama R, Yang X, Araki T, Sato M, Iwashige S, Tanigawa Y, Uchimura M, Ishimaru K, Sasaki Y, Kamimura Y, Maeda H.Keratoconus in a cynomolgus monkey. J Toxicol Pathol. 2010; 23(1): 53-58. [23]Meyer CH, Mennel S, Schmidt JC. Schmidt. Acute keratoconus-like hydrops after laser in situ keratomileusis. J Ophthalmology. 2009; 363482. [24]McMahon TT, Szczotka-Flynn L, Barr JT, Anderson RJ, Slaughter ME, Lass JH, Iyengar SK; CLEK Study Group. A new method for grading the severity of keratoconus. The Keratoconus Severity Score (KSS). Cornea 2006; 25(7): 794-800. [25]Sydney Stephenson. The Ophthalmoscope. London:Forgotten Books. 2013; 11: 370-371. [26]Stoiber J, Muss W, Ruckhofer J, Grabner G. Acute keratoconus with perforation in a patient with Down’s syndrome. Br J Ophthalmol.2003; 87(1): 120. [27]Bron AJ, Rabinowitz YS. Corneal dystrophies and keratoconus. Curr Opin Ophthalmol. 1996; 7(4): 71-82. [28]Sardar Bahadur Khan, Mohammad Saleem, Mohammad Kamran Khalid, Iftikhar Ahmad Mohammad Daud Khan. Keratoconus and its Association with Other Ocular Diseases. Pak J Ophthalmol. 2007; 23(4): 212-217. [29]Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol. 1984; 28(4): 293-322. [30]Monnies CW. Abnormal rubbing and keractectasia. Eye Contact Lens. 2007; 33 (6 Pt 1): 265-271. [31]Tachibana M, Okamoto M, Sakamoto M, Matsushima Y. Hereditary keratoconus-like keratopathy in Japanese wild mice mapped to mouse Chromosome 13. Mammalian Genome. 2002; 13(12): 692-695. [32]Chwa M, Atilano SR, Reddy V, Jordan N, Kim DW, Kenney MC. Increased stress-induced generation of reactive oxygen species and apoptosis in human keratoconus fibroblasts. Invest Ophthalmol. 2006; 47(5): 1902-1910. [33]Buddi, R. Lin, B. Atilano, SR. Zorapapel, NC. Kenney, MC. Brown, DJ. Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem. 2002; 50(3): 341-351. [34]Arnal E, Peris-Martínez C, Menezo JL, Johnsen-Soriano S, Romero FJ. Oxidative stress in keratoconus? Invest Ophthalmol. Vis Sci. 2011; 52(12): 8592-8597. [35]Uchida, K. Role of reactive aldehyde in cardiovascular diseases. Biol Med. 2000; 28(12): 1685-1696. [36]White HL, Scates PW, Cooper BR. Extracts of Ginkgo biloba leaves inhibit monoamine oxidase. Life Sci. 1996; 58(16): 1315-1321. [37]Logani S, Chen MC, Tran T, Le T, Raffa RB. Actions of Ginkgo bilobarelated to potential utility for the treatment of conditions in volvingerebral hypoxia. Life Sci. 2000; 67(12): 1389-1396. [38]Mahady GB. Ginkgo biloba: A review of quality, safety, and efficacy. Nutr Clin Care. 2001; 4(3): 140-147. [39]Singh B, Kaur P, Gopichand, Singh RD, Ahuja PS. Biology and chemistry of Ginkgo biloba. Fitoterapia. 2008; 79(6): 401-418. [40]Kleijnen J, Knipschild P. Ginkgo biloba for cerebral insufficiency. Brit J Clin Pharmacol. 1992; 34(4): 352-358. [41]Gakhramanov FS. Effect of Natural Antioxidants on Antioxidant Activity and Lipid Peroxidation in Eye Tissue of Rabbits with Chemical Burns. Bull Exp Biol Med. 2005; 140(3): 289-291. [42]R. Ritch. Potential role for Ginkgo biloba extract in the treatment of glaucoma. Medical Hypotheses. 2000; 54(2): 221-235. [43]Kim SJ. Effect of biflavones of Ginkgo biloba against UVB-induced Cytotoxicity In vitro. J Dermatol. 2001; 28(4): 193-199. [44]Yu-Rong Siao. Ginkgo Biloba Leaf extract recovers mouse vision related functions and protects against retinal degeneration induced by LED. School of Biomedical Sciences, Chung Shan Medical University, Master Thesis. 2014. [45]Tzu-Ping Huang. Analysis of the in vivo preventive effect against UVB-induced ocular surface damage by Ginkgo Biloba Leaf Eetract. School of Biomedical Sciences, Chung Shan Medical University, Master Thesis. 2013. [46] T. Hori, Robert W. Ridge, Walter Tulecke, Peter Del Tredici, Jocelyne Tremouillaux-Guiller, Hiroshi Tobe. Ginkgo Biloba A Global Treasure: From Biology to Medicine. Springer. 2012 [47]Po-Chuen Chan, Qingsu Xia, and Peter P. Fu. Ginkgo Biloba Leave Extract: Biological, Medicinal, and Toxicological Effects. Journal of Environmental Science and Health Part C. 2007; 25:211-244. [48]Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2012; 46(1-3): 3-26. [49]Rytting E, Lentz KA, Chen XQ, Qian F, Venkatesh S. A Quantitative Structure–Property Relationship for Predicting Drug Solubility in PEG 400/Water Cosolvent Systems. Pharmaceutical Research. 2004; 21(2): 237-244. [50]Zhao J, Mo V, Nagasaki T. Distribution of label-retaining cells in the limbal epithelium of a mouse eye. J Histochem Cytochem. 2009; 57(2): 177-185. [51]Pellegrini G, Traverso CE, Franzi AT, Zingirian M, Cancedda R, De Luca M. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet. 1997; 349(9057): 990-993. [52]Lipman RM, Rubenstein JB, Torczynski E. Keratoconus and Fuchs’ Corneal Endothelial Dystrophy in a Patient and her Family. Arch Ophthalmol. 1990; 108(7): 993-994. [53]Polack FM. Keratocyte loss after corneal deepithelialization in primates and rabbits. Arch Ophthalmol. 1994; 112(2): 254-260. [54]Ivarsen, A, Laurberg, T, and Moller-Pedersen, T. Role of keratocyte loss on corneal wound repair after LASIK. Invest Ophthalmol Vis Sci. 2004; 45(10): 3499-3506. [55]Edward J. Holland, Mark J. Mannis, W. Barry Lee .Ocular Surface Disease: Cornea, Conjunctiva and Tear Film. HEALTH & FITNESS. 2013. [56]Riley MV, Susan S, Peters MI, Schwartz CA. The effects of UV-B irradiation on the corneal endothelium. Curr Eye Res.1987; 6(8): 1021-1033. [57]Cauchi P, Azuara-Blanco A, McKenzie J. Corneal Toxicity and Inflammation Secondary to Retained Perfluorodecalin. Am J Ophthalmol. 2005; 140(2): 322-323.
|